PathoQuest SAS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PathoQuest SAS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10478
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PathoQuest SAS (PathoQuest) is a biotechnology company that provides game changing metagenomics approach to improve the breadth of pathogen detection. The company provides automated bioinformatics software that offers comprehensive pathogens database to produce microbiome reports. Its testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical managers and production managers, among others. PathoQuest provides services such as viral safety testing, adventitious virus detection and screening; and sequences identification services. The company offers product such as proprietary sample preparation, bio-IT pipelines and proposes microbial whole genome NGS from clinical samples. It also develops solutions for bacterial and fungal overgrowth infections. PathoQuest is headquartered in Paris, France.

PathoQuest SAS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PathoQuest SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PathoQuest SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PathoQuest SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PathoQuest SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
PathoQuest SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PathoQuest SAS, Medical Equipment, Deal Details 10
Venture Financing 10
PathoQuest Raises US$5 Million In Series B Financing 10
Partnerships 12
Laboratoire Cerba Enters into Licensing Agreement with PathoQuest for iDTECT Blood test 12
PathoQuest Enters into Agreement with Memorial Sloan Kettering 13
Charles River and PathoQuest Expand Biologics Partnership 14
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 15
PathoQuest SAS – Key Competitors 16
PathoQuest SAS – Key Employees 17
PathoQuest SAS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Sep 25, 2018: PathoQuest appoints Dr. Christiane Honisch to Board of Directors 19
Jul 10, 2018: PathoQuest Announces New Appointments to Executive Leadership Team 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PathoQuest SAS, Medical Equipment, Key Facts 2
PathoQuest SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PathoQuest SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PathoQuest SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PathoQuest SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PathoQuest SAS, Deals By Market, 2012 to YTD 2018 8
PathoQuest SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PathoQuest Raises US$5 Million In Series B Financing 10
Laboratoire Cerba Enters into Licensing Agreement with PathoQuest for iDTECT Blood test 12
PathoQuest Enters into Agreement with Memorial Sloan Kettering 13
Charles River and PathoQuest Expand Biologics Partnership 14
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 15
PathoQuest SAS, Key Competitors 16
PathoQuest SAS, Key Employees 17

List of Figures
PathoQuest SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PathoQuest SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PathoQuest SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PathoQuest SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PathoQuest SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PathoQuest SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
PathoQuest SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PathoQuest SAS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[PathoQuest SAS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Actuant Corporation:企業の戦略・SWOT・財務情報
    Actuant Corporation - Strategy, SWOT and Corporate Finance Report Summary Actuant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genworth Financial, Inc.:企業の戦略・SWOT・財務情報
    Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Applied Industrial Technologies Inc (AIT):石油・ガス:M&Aディール及び事業提携情報
    Summary Applied Industrial Technologies Inc. (Applied Industrial) is a distributor of industrial products and services to MRO and OEM customers. The company also provides engineering, design and systems integration services for industrial and fluid power applications, besides tailored mechanical, fa …
  • Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sekisui House, Ltd.:企業の戦略・SWOT・財務情報
    Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PharmAust Ltd (PAA)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory suppo …
  • Questerre Energy Corp (QEC):企業の財務・戦略的SWOT分析
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Entellus Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Entellus Medical Inc (Entellus Medical), a subsidiary of Stryker Corp, is a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation system, …
  • mAbxience SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …
  • Troms Offshore Supply AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Troms Offshore Supply AS (Troms Offshore), a subsidiary of Tidewater Inc, is a offshore service provider that owns and operates offshore service vessels and other special vessels related to research and sub sea activities. The company’s fleet includes platform supply vessels, polar research …
  • BHP:企業の戦略・SWOT・財務情報
    BHP - Strategy, SWOT and Corporate Finance Report Summary BHP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Accent Group Ltd (AX1):企業の財務・戦略的SWOT分析
    Accent Group Ltd (AX1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Puget Energy, Inc.:戦略・SWOT・企業財務分析
    Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • Hexza Corp Bhd (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corp Bhd (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Investment Technology Group, Inc.
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Yangarra Resources Ltd (YGR):企業の財務・戦略的SWOT分析
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):企業の財務・戦略的SWOT分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, anti-tumor medication, respiratory medication, …
  • Murphy Oil Corporation:企業の戦略・SWOT・財務分析
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆